Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience.

Santoro A, Piermattei A, Inzani F, Angelico G, Valente M, Arciuolo D, Spadola S, Martini M, Fanfani F, Fagotti A, Gallotta V, Scambia G, Zannoni GF.

BMC Cancer. 2019 Nov 12;19(1):1096. doi: 10.1186/s12885-019-6318-5.

PMID:
31718623
2.

Hemangioma of the umbilical cord with associated amnionic inclusion cyst: two uncommon entities occurring simultaneously.

Angelico G, Spadola S, Ieni A, Gurrera A, Arena MG, Arciuolo D, Valente M, Santoro A, Inzani F, Zannoni GF.

Pathologica. 2019 Jun;111(2):86.

PMID:
31596275
3.

Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases.

Bennett JA, Ritterhouse LL, Furtado LV, Lastra RR, Pesci A, Newell JM, Burandt E, Kooreman L, Van de Vijver K, Krausz T, Felix A, Zannoni GF, Young RH, Oliva E.

Mod Pathol. 2019 Oct 7. doi: 10.1038/s41379-019-0375-9. [Epub ahead of print]

PMID:
31591497
4.

Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4.

Lucà R, di Blasio G, Gallo D, Monteleone V, Manni I, Fici L, Buttarelli M, Ciolli G, Pellegrino M, Teveroni E, Maiullari S, Ciucci A, Apollo A, Mancini F, Gentileschi MP, Zannoni GF, Pontecorvi A, Scambia G, Moretti F.

Cancers (Basel). 2019 Sep 12;11(9). pii: E1349. doi: 10.3390/cancers11091349.

5.

Pathological Chemotherapy Response Score in Patients Affected by High Grade Serous Ovarian Carcinoma: The Prognostic Role of Omental and Ovarian Residual Disease.

Santoro A, Angelico G, Piermattei A, Inzani F, Valente M, Arciuolo D, Spadola S, Mulè A, Zorzato P, Fagotti A, Scambia G, Zannoni GF.

Front Oncol. 2019 Aug 19;9:778. doi: 10.3389/fonc.2019.00778. eCollection 2019.

6.

Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial Cancer.

Raffone A, Travaglino A, Santoro A, Esposito I, Angelico G, Spadola S, Zannoni GF.

Pathol Oncol Res. 2019 Aug 23. doi: 10.1007/s12253-019-00727-9. [Epub ahead of print] Review.

PMID:
31444708
7.

Clear cell endometrial carcinoma and the TCGA classification.

Travaglino A, Raffone A, Mascolo M, Guida M, Insabato L, Zannoni GF, Zullo F.

Histopathology. 2019 Aug 21. doi: 10.1111/his.13976. [Epub ahead of print] No abstract available.

PMID:
31433862
8.

A new entity in the pathological spectrum of vulvar neoplasms: The first report of a primary endometrioid adenocarcinoma.

Inzani F, Angelico G, Santoro A, Musarra T, Valente M, Spadola S, Garganese G, Fragomeni S, Scambia G, Zannoni GF.

Int J Gynaecol Obstet. 2019 Nov;147(2):270-272. doi: 10.1002/ijgo.12936. Epub 2019 Aug 20.

PMID:
31372981
9.

Uterine smooth muscle tumors of unknown malignant potential: A challenging question.

Gadducci A, Zannoni GF.

Gynecol Oncol. 2019 Sep;154(3):631-637. doi: 10.1016/j.ygyno.2019.07.002. Epub 2019 Jul 17. Review.

PMID:
31326137
10.

The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease.

Garganese G, Inzani F, Mantovani G, Santoro A, Valente M, Babini G, Petruzzellis G, Fragomeni SM, Gentileschi S, Bove S, Franchi M, Angelico G, Fagotti A, Scambia G, Zannoni GF.

J Cancer Res Clin Oncol. 2019 Sep;145(9):2211-2225. doi: 10.1007/s00432-019-02975-3. Epub 2019 Jul 11.

PMID:
31297606
11.

Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases.

Zannoni GF, Santoro A, Angelico G, Spadola S, Arciuolo D, Valente M, Inzani F, Pettinato A, Vatrano S, Fanfani F, Scambia G, Fraggetta F.

Hum Pathol. 2019 Jun 30;92:10-17. doi: 10.1016/j.humpath.2019.06.005. [Epub ahead of print]

PMID:
31269413
12.

Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases.

Gallotta V, Conte C, D'Indinosante M, Capoluongo E, Minucci A, De Rose AM, Ardito F, Giuliante F, Di Giorgio A, Zannoni GF, Fagotti A, Margreiter C, Scambia G, Ferrandina G.

Eur J Surg Oncol. 2019 Nov;45(11):2096-2102. doi: 10.1016/j.ejso.2019.06.023. Epub 2019 Jun 13.

PMID:
31227342
13.

Hemangioma of the umbilical cord with associated amnionic inclusion cyst: two uncommon entities occurring simultaneously.

Angelico G, Spadola S, Ieni A, Gurrera A, Arena MG, Arciuolo D, Valente M, Santoro A, Inzani F, Zannoni GF.

Pathologica. 2019 Mar;111(1):13-17. doi: 10.32074/1591-951X-26-17. Erratum in: Pathologica. 2019 Jun;111(2):86.

PMID:
31217617
14.

Intra-operative assessment of sentinel lymph node status by one-step nucleic acid amplification assay (OSNA) in early endometrial cancer: a prospective study.

Monterossi G, Buca D, Dinoi G, La Fera E, Zannoni GF, Spadola S, Scambia G, Fanfani F.

Int J Gynecol Cancer. 2019 Jul;29(6):1016-1020. doi: 10.1136/ijgc-2018-000113. Epub 2019 Jun 6.

PMID:
31175137
15.

Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: Results from a comparative cytohistological study.

Angelico G, Santoro A, Inzani F, Spadola S, Fiorentino V, Cianfrini F, Carbone C, Garganese G, Rossi ED, Scambia G, Zannoni GF.

Cancer Cytopathol. 2019 Aug;127(8):514-520. doi: 10.1002/cncy.22154. Epub 2019 Jun 7.

PMID:
31174235
16.

The role of sentinel node in early ovarian cancer: a systematic review.

Uccella S, Zorzato PC, Lanzo G, Fagotti A, Cianci S, Gallina D, Gueli Alletti S, Monterossi G, Franchi M, Ghezzi F, Zannoni GF, Scambia G.

Minerva Med. 2019 Aug;110(4):358-366. doi: 10.23736/S0026-4806.19.06145-7. Epub 2019 May 22.

PMID:
31124639
17.

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.

Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S, Brockbank EC, Bosse T, de Azevedo Focchi GR, Ganesan R, Glasspool RM, Howitt BE, Kim HS, Lee JY, Le ND, Lockley M, Manchanda R, Mandalia T, McCluggage WG, McNeish I, Midha D, Srinivasan R, Tan YY, van der Griend R, Yunokawa M, Zannoni GF; HGSC CRS Collaborative Network (Supplementary 1), Singh N.

Gynecol Oncol. 2019 Aug;154(2):441-448. doi: 10.1016/j.ygyno.2019.04.679. Epub 2019 May 19. Review.

18.

Ultrasound features of chromophobe renal carcinoma metastatic to the ovary.

Moro F, Bertoldo V, Borzi R, Zannoni GF, Testa AC.

Ultrasound Obstet Gynecol. 2019 May 7. doi: 10.1002/uog.20307. [Epub ahead of print] No abstract available.

PMID:
31063651
19.

Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes.

Nero C, Fagotti A, Zannoni GF, Palluzzi E, Scambia G, Petrillo M.

Int J Gynecol Cancer. 2019 Jul;29(6):1064-1071. doi: 10.1136/ijgc-2019-000232. Epub 2019 May 5.

PMID:
31061096
20.

Imaging of gynecological disease: clinical and ultrasound characteristics of serous cystadenofibromas in the adnexa.

Virgilio BA, De Blasis I, Sladkevicius P, Moro F, Zannoni GF, Arciuolo D, Mascilini F, Ciccarone F, Timmerman D, J K, Fruscio R, Van Holsbeke C, Franchi D, Epstein E, Leone FPG, Guerriero S, Czekierdowski A, Scambia G, Testa AC, Valentin L.

Ultrasound Obstet Gynecol. 2019 Apr 1. doi: 10.1002/uog.20277. [Epub ahead of print]

PMID:
30937992
21.

Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma.

Ludovisi M, Moro F, Pasciuto T, Di Noi S, Giunchi S, Savelli L, Pascual MA, Sladkevicius P, Alcazar JL, Franchi D, Mancari R, Moruzzi MC, Jurkovic D, Chiappa V, Guerriero S, Exacoustos C, Epstein E, Frühauf F, Fischerova D, Fruscio R, Ciccarone F, Zannoni GF, Scambia G, Valentin L, Testa AC.

Ultrasound Obstet Gynecol. 2019 Nov;54(5):676-687. doi: 10.1002/uog.20270. Epub 2019 Oct 7.

PMID:
30908820
22.

Uncommon Mixed Endometrial-Myometrial Benign Tumors of the Reproductive Tract: Literature Review.

Habiba M, Brosens I, Zannoni GF, Benagiano G.

Gynecol Obstet Invest. 2019;84(6):521-547. doi: 10.1159/000499019. Epub 2019 Mar 19. Review.

PMID:
30889596
23.

Tamoxifen related Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A case report and literature review of this possible association.

Segala D, Gobbo S, Pesci A, Martignoni G, Santoro A, Angelico G, Arciuolo D, Spadola S, Valente M, Scambia G, Zannoni GF.

Pathol Res Pract. 2019 May;215(5):1089-1092. doi: 10.1016/j.prp.2019.01.039. Epub 2019 Jan 28. Review.

PMID:
30799070
24.

Presumed early ovarian cancer with isolated tumor cells in para-aortic sentinel nodes.

Uccella S, Fagotti A, Zannoni GF, Coleman RL.

Int J Gynecol Cancer. 2019 Jan;29(1):216-220. doi: 10.1136/ijgc-2018-000005. No abstract available.

PMID:
30640707
25.

Clinical and Ultrasound Characteristics of the Microcystic Elongated and Fragmented (MELF) Pattern in Endometrial Cancer According to the International Endometrial Tumor Analysis (IETA) criteria.

Eriksson LSE, Nastic D, Frühauf F, Fischerova D, Nemejcova K, Bono F, Franchi D, Fruscio R, Ghioni M, Haak LA, Hejda V, Meskauskas R, Opolskiene G, Pascual MA, Testa A, Tresserra F, Zannoni GF, Carlson JW, Epstein E.

Int J Gynecol Cancer. 2019 Jan;29(1):119-125. doi: 10.1136/ijgc-2018-000045.

PMID:
30640693
26.

Synchronous primary cancers of endometrium and ovary vs endometrial cancer with ovarian metastasis: an observational study.

Moro F, Leombroni M, Pasciuto T, Trivellizzi IN, Mascilini F, Ciccarone F, Zannoni GF, Fanfani F, Scambia G, Testa AC.

Ultrasound Obstet Gynecol. 2019 Jun;53(6):827-835. doi: 10.1002/uog.20213. Epub 2019 May 3.

PMID:
30620432
27.

Peritoneal Carcinomatosis From Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma.

Angelico G, Santoro A, Arciuolo D, Valente M, Carbone V, Fagotti A, Scambia G, Zannoni GF.

Int J Gynecol Pathol. 2018 Oct 31. doi: 10.1097/PGP.0000000000000562. [Epub ahead of print] No abstract available.

PMID:
30383611
28.

Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the "PRICE" study 2: role of conventional and DW-MRI.

Gui B, Miccò M, Valentini AL, Cambi F, Pasciuto T, Testa A, Autorino R, Zannoni GF, Rufini V, Gambacorta MA, Giordano A, Scambia G, Manfredi R.

Eur Radiol. 2019 Apr;29(4):2045-2057. doi: 10.1007/s00330-018-5768-5. Epub 2018 Oct 15.

PMID:
30324389
29.

Cerebellar Metastasis From Ovarian Carcinoma Harboring PIK3CA-Activating Mutation: A "Clear" Explanation for an Unexpected "Vertigo".

Piermattei A, Santoro A, Angelico G, Inzani F, Valente M, Pettinato A, Vatrano S, Scambia G, Fraggetta F, Zannoni GF.

Int J Gynecol Pathol. 2018 Sep 24. doi: 10.1097/PGP.0000000000000550. [Epub ahead of print]

PMID:
30252727
30.

Radical Surgery in Advanced Cervical Cancer Patients Receiving Bevacizumab-Containing Chemotherapy: A "Real Life Experience".

Fagotti A, Conte C, Stollagli F, Gallotta V, Salutari V, Bottoni C, Bruno M, Zannoni GF, Scambia G.

Int J Gynecol Cancer. 2018 Oct;28(8):1569-1575. doi: 10.1097/IGC.0000000000001350.

PMID:
30157167
31.

Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome.

De Vincenzo R, Tortorella L, Ricci C, Cavaliere AF, Zannoni GF, Cefalo MG, Scambia G, Fagotti A.

Gynecol Oncol. 2018 Sep;150(3):398-405. doi: 10.1016/j.ygyno.2018.06.028. Epub 2018 Jul 4.

PMID:
30126588
32.

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports.

Santoro A, Angelico G, Arciuolo D, Inzani F, Fanfani F, Romualdi D, Scambia G, Zannoni GF.

Medicine (Baltimore). 2018 Aug;97(31):e11532. doi: 10.1097/MD.0000000000011532.

33.

Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.

Bennett JA, Braga AC, Pinto A, Van de Vijver K, Cornejo K, Pesci A, Zhang L, Morales-Oyarvide V, Kiyokawa T, Zannoni GF, Carlson J, Slavik T, Tornos C, Antonescu CR, Oliva E.

Am J Surg Pathol. 2018 Oct;42(10):1370-1383. doi: 10.1097/PAS.0000000000001119.

34.

Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.

Moro F, Pasciuto T, Djokovic D, Di Legge A, Granato V, Moruzzi MC, Mancari R, Zannoni GF, Fischerova D, Franchi D, Scambia G, Testa AC.

Ultrasound Obstet Gynecol. 2019 Jan;53(1):116-123. doi: 10.1002/uog.19174.

35.

Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma.

Pozzati F, Moro F, Pasciuto T, Gallo C, Ciccarone F, Franchi D, Mancari R, Giunchi S, Timmerman D, Landolfo C, Epstein E, Chiappa V, Fischerova D, Fruscio R, Zannoni GF, Valentin L, Scambia G, Testa AC.

Ultrasound Obstet Gynecol. 2018 Dec;52(6):792-800. doi: 10.1002/uog.19171.

PMID:
29978567
36.

Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases.

Losi L, Botticelli L, Taccagni G, Longinotti E, Lancellotti C, Scurani L, Zannoni GF.

Gynecol Oncol Rep. 2018 Mar 13;24:39-42. doi: 10.1016/j.gore.2018.03.003. eCollection 2018 May.

37.

Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors?

Ciucci A, Ferrandina G, Mascilini F, Filippetti F, Scambia G, Zannoni GF, Gallo D.

Gynecol Oncol. 2018 Jul;150(1):158-165. doi: 10.1016/j.ygyno.2018.05.013. Epub 2018 May 18.

PMID:
29786517
38.

One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer.

Fanfani F, Monterossi G, Ghizzoni V, Rossi ED, Dinoi G, Inzani F, Fagotti A, Gueli Alletti S, Scarpellini F, Nero C, Santoro A, Scambia G, Zannoni GF.

PLoS One. 2018 Apr 26;13(4):e0195877. doi: 10.1371/journal.pone.0195877. eCollection 2018.

39.

Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity.

Nestola M, De Matthaeis N, Ferraro PM, Fuso P, Costanzi S, Zannoni GF, Pizzolante F, Vasquez Quadra S, Gambaro G, Rapaccini GL.

J Ultrasound. 2018 Jun;21(2):81-87. doi: 10.1007/s40477-018-0298-1. Epub 2018 Apr 24.

40.

Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.

Improta G, Pettinato A, Høgdall E, Santeusanio G, Vatrano S, Fraggetta F, Zannoni GF.

Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):631-636. doi: 10.1097/PAI.0000000000000662.

PMID:
29629954
41.

Near-Infrared Imaging with Indocyanine Green for Detection of Endometriosis Lesions (Gre-Endo Trial): A Pilot Study.

Cosentino F, Vizzielli G, Turco LC, Fagotti A, Cianci S, Vargiu V, Zannoni GF, Ferrandina G, Scambia G.

J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1249-1254. doi: 10.1016/j.jmig.2018.02.023. Epub 2018 Mar 15.

PMID:
29551477
42.

Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer.

Martinelli E, Fattorossi A, Battaglia A, Petrillo M, Raspaglio G, Zannoni GF, Fanelli M, Gallo D, Scambia G.

Transl Oncol. 2018 Apr;11(2):358-365. doi: 10.1016/j.tranon.2018.01.016. Epub 2018 Feb 20.

43.

Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer.

Moro F, Magoga G, Pasciuto T, Mascilini F, Moruzzi MC, Fischerova D, Savelli L, Giunchi S, Mancari R, Franchi D, Czekierdowski A, Froyman W, Verri D, Epstein E, Chiappa V, Guerriero S, Zannoni GF, Timmerman D, Scambia G, Valentin L, Testa AC.

Ultrasound Obstet Gynecol. 2018 Oct;52(4):535-543. doi: 10.1002/uog.19026.

44.

Routine Digital Pathology Workflow: The Catania Experience.

Fraggetta F, Garozzo S, Zannoni GF, Pantanowitz L, Rossi ED.

J Pathol Inform. 2017 Dec 19;8:51. doi: 10.4103/jpi.jpi_58_17. eCollection 2017.

45.

Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma.

Gallotta V, D'Indinosante M, Nero C, Giudice MT, Conte C, Lodoli C, Zannoni GF, Fagotti A, Scambia G.

J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):774-775. doi: 10.1016/j.jmig.2017.10.034. Epub 2017 Nov 8.

PMID:
29128439
46.

PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.

Testa AC, Moro F, Pasciuto T, Moruzzi MC, Di Legge A, Fuoco G, Autorino R, Collarino A, Gui B, Zannoni GF, Gambacorta A, Miccò M, Rufini V, Scambia G, Ferrandina G.

Ultrasound Obstet Gynecol. 2018 Jul;52(1):110-118. doi: 10.1002/uog.18953.

47.

Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors.

Moro F, Zannoni GF, Arciuolo D, Pasciuto T, Amoroso S, Mascilini F, Mainenti S, Scambia G, Testa AC.

Ultrasound Obstet Gynecol. 2017 Aug;50(2):261-270. doi: 10.1002/uog.17222. Epub 2017 Jun 22.

48.

Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: an observational study.

Lio A, Rosati P, Pastorino R, Cota F, Tana M, Tirone C, Aurilia C, Ricci C, Gambacorta A, Paladini A, Mappa I, Buongiorno S, Zannoni GF, Romagnoli C, Vento G.

BMJ Open. 2017 Jul 20;7(7):e015232. doi: 10.1136/bmjopen-2016-015232.

49.

Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations.

Gallotta V, Ferrandina G, Vizzielli G, Conte C, Lucidi A, Costantini B, De Rose AM, Di Giorgio A, Zannoni GF, Fagotti A, Scambia G, Chiantera V.

Ann Surg Oncol. 2017 Oct;24(11):3413-3421. doi: 10.1245/s10434-017-6005-1. Epub 2017 Jul 17.

PMID:
28718034
50.

PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.

Testa AC, Ferrandina G, Moro F, Pasciuto T, Moruzzi MC, De Blasis I, Mascilini F, Foti E, Autorino R, Collarino A, Gui B, Zannoni GF, Gambacorta MA, Valentini AL, Rufini V, Scambia G.

Ultrasound Obstet Gynecol. 2018 May;51(5):684-695. doi: 10.1002/uog.17551.

Supplemental Content

Loading ...
Support Center